FDA Drug Application (022122) for VOLTAREN by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number022122
Product Number001
FormGEL;TOPICAL
Dosage1%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVOLTAREN
Active IngredientDICLOFENAC SODIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOFENAC SODIUM8


Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS